The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
In general, the higher your C-reactive protein, which is the general marker of inflammation in your body, we call it CRP, and the test order is hsCRP, or high-sensitivity CRP. If your CRP is higher, then your reactive oxygen species, which are causing mutations and atypical cell turnover in the prostate are also likely higher.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.